FilingFirehose · free AI preview
Pasithea Therapeutics Corp.
KTTA · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Pasithea Therapeutics Corp. (KTTA) filed an 8-K on May 4, 2026 disclosing an officer departure, a material event that warrants closer examination of leadership transitions and their potential impact on clinical programs and strategy. Beyond this headline filing, the company's financing history, equity dilution trajectory, and AI-detected risk signals require fuller context to assess shareholder value implications. The full $49 Report adds a dilution risk score based on historical capital raises, detailed 8-K context analysis, 12-month filing review, and our proprietary AI risk signals across governance and disclosure patterns.
Want the full 5-section $49 Report on KTTA?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.